FDA Warning Letter — OneBlood, Inc.

Case 285017 — FEI 1077496

The FDA took a Warning Letter action against OneBlood, Inc. on April 27, 2012 (Fort Lauderdale, FL). The action was issued by CBER and concerns biologics products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
OneBlood, Inc.
Date
April 27, 2012
Fiscal Year
2012
Product Type
Biologics
Center
CBER
Location
Fort Lauderdale, FL (United States)